Background
Dr. Hla Htay has been working with Burnet Institute Myanmar since 2006.
After his graduation from Institute of Medicine (1) in Yangon, Myanmar, he started his career to provide medical assistance to needy people in very remote areas of Mon and Karen States, specifically in the Thai-Burmese border region by working with Médecins Sans Frontières (MSF) in Myanmar. He has risked his life for humanitarian assistance in such insecure and difficult-to-access villages.
He pursued further study for a Master of Public Health at Mahidol University, Thailand with a special focus on Primary Health Care in 2005.
After completing his further study, he joined Burnet Institute Myanmar. Dr Hla Htay plays pivotal roles in various technical and program management areas including HIV, TB, Malaria, Research and Organisation Development. He has extensive knowledge and understanding in working with highly stigmatised and discriminated people.
His current position is Senior Technical Manager and he oversees all the technical support for implementation of programs and projects.
Appointments
- Myanmar Organization Development Network
- DU Working Group
- Myanmar Positive Group (MPG)
- Education Thematic Working Group (ETWG)
- Yaung Zin Teacher Development Group
- Myanmar Teacher Education Working Group (MTEWG)
Positions
- Senior Technical Manager
- Senior Technical Officer (Organisation Development)
- Thematic Coordinator (Organisation Development)
- Thematic Coordinator (Drugs and Society Team)
- Project Officer (Centre for Harm Reduction)
Qualifications
- MBBS, Institute of Medicine (1), Yangon, Myanmar
- MPH, Mahidol University, Bangkok, Thailand
Awards
- Crockett-Murphy Travel Award (2014-2015)
Projects (10)
Current (4)
-
Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar (ACCESS Myanmar)
-
Feasibility and Outcomes of the Public Sector Hepatitis C Treatment Program in Myanmar
-
Hepatitis C: Community Testing and Treatment (CT2)
-
Modelling hepatitis C virus elimination and control policies in Myanmar
Past (1)
Publications (9)
2023 (1)
- The effect of the Xpert HIV-1 Qual test on early infant diagnosis of HIV in Myanmar and Papua New Guinea: a pragmatic, cluster-randomised, stepped-wedge, open-label trial.
Mohamed Y, Htay H, Gare J, Vallely AJB, Kelly-Hanku A, Yee WL, Agius PA, Badman SG, Pham MD, Nightingale C, Chen XS, Kombati Z, Koata A, Munnull G, Silim S, Thein W, Zaw TM, Kyaw LL, Stoové M, Crowe SM, Anderson D, Tin HH, Luchters S
Lancet HIV. 2023 Mar; Epub ahead of print
2022 (3)
- Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study.
Yee WL, Draper B, Myint KT, Min W, Htay H, O'Keefe D, Hellard M
Harm Reduct J. 2022 Sep; 19(1):107
- Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up.
Draper BL, Yee WL, Shilton S, Bowring A, Htay H, Nwe N, Markby J, Kyi KP, Easterbrook P, Naing W, Win TM, Aung KS, Howell J, Pedrana A, Hellard M
BMJ Open. 2022 May; 12(5):e059639
- Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients.
Draper B, Yee WL, Pedrana A, Kyi KP, Qureshi H, Htay H, Naing W, Thompson AJ, Hellard M, Howell J
Lancet Reg Health West Pac. 2022 Mar; 20:100359
2021 (3)
- Operational experiences associated with the implementation of near point-of-care early infant diagnosis of HIV in Myanmar: a qualitative study.
Yee WL, Htay H, Mohamed Y, Nightingale CE, Tin HH, Thein W, Kyaw LL, Yee WW, Aye MM, Badman SG, Vallely AJ, Anderson D, Kelly-Hanku A, Luchters S
BMC Health Serv Res. 2021 Aug; 21(1):863
- Outcomes of the CT2 Study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar.
Draper B, Htay H, Pedrana A, Yee WL, Howell J, Kyi KP, Naing W, Aung KS, Markby J, Easterbrook P, Bowring A, Aung W, Sein YY, Nwe N, Myint KT, Shilton S, Hellard M
Liver Int. 2021 Jun; 41(11):2578-2589
- Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits.
Scott N, Win TM, Tidhar T, Htay H, Draper B, Aung PTZ, Xiao Y, Bowring A, Kuschel C, Shilton S, Kyi KP, Naing W, Aung KS, Hellard M
Lancet Reg Health West Pac. 2021 May; 10:100129
2020 (2)
- Caregiver experience and perceived acceptability of a novel near point-of-care early infant HIV diagnostic test among caregivers enrolled in the PMTCT program, Myanmar: A qualitative study.
Yee WL, Than KK, Mohamed Y, Htay H, Tin HH, Thein W, Kyaw LL, Yee WW, Aye MM, Badman SG, Vallely AJ, Luchters S, Kelly-Hanku A; AAMI study group
PLoS One. 2020 Oct; 15(10):e0241245
- Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study.
Draper BL, Pedrana A, Howell J, Yee WL, Htay H, Aung KS, Shilton S, Kyi KP, Naing W, Hellard M
JMIR Res Protoc. 2020 Jul; 9(7):e16863
News Articles (1)
2021 (1)
